Latest News about ANGN
Recent news which mentions ANGN
Angion Biomedica Is 'Better Positioned' Than Peers Despite Trial Failure, HC Wainwright Thinks So
April 18, 2022
Tickers
ANGN
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
March 02, 2022
From Benzinga
52 Biggest Movers From Friday
January 31, 2022
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets
January 05, 2022
From Benzinga
63 Biggest Movers From Yesterday
December 31, 2021
From Benzinga
44 Stocks Moving In Thursday's Mid-Day Session
December 30, 2021
From Benzinga
50 Biggest Movers From Friday
December 13, 2021
From Benzinga
Mid-Afternoon Market Update: Dow Rises 150 Points; SigmaTron International Shares Spike Higher
December 10, 2021
From Benzinga
36 Stocks Moving In Friday's Mid-Day Session
December 10, 2021
From Benzinga
Mid-Day Market Update: Oracle Gains Following Upbeat Q2 Results; Angion Biomedica Shares Drop
December 10, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: Lilly Sings Metabolic Disorder Drug Pact, Moderna Reports Positive Flu Vaccine Data, Halozyme To Buy Back Shares
December 10, 2021
From Benzinga
Angion's ANG-3777 Faces Third Failure In 2021, This Time Flunks Acute Kidney Injury Trial
December 10, 2021
Tickers
ANGN
From Benzinga
64 Biggest Movers From Yesterday
October 28, 2021
From Benzinga
Mid-Afternoon Market Update: Nasdaq Surges Over 100 Points; Cortexyme Shares Plunge
October 27, 2021
From Benzinga
Mid-Day Market Update: Dow Falls Over 100 Points; Silicon Laboratories Shares Spike Higher
October 27, 2021
From Benzinga
Why Did Angion Biomedica's Shares tumble Premarket Today?
October 27, 2021
Tickers
ANGN
From Benzinga
From InvestorPlace
28 Stocks Moving in Wednesday's Pre-Market Session
October 27, 2021
From Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
From Benzinga
From Benzinga
From Benzinga
77 Biggest Movers From Yesterday
August 13, 2021
From Benzinga
85 Biggest Movers From Yesterday
August 11, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
More ways to get to us
Facebook
Twitter
YouTubeContact the Lethbridge Herald
504 - 7th Street South
Lethbridge, AB T1J 3Z7
[P] (403) 328-4411
[F] (403)328-4536
Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.